Reviva Pharmaceuticals News

SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Parag Saxena(18.5%),Vedanta Partners, LLC(15.9%), etc.

Jun 1 09:34

424B5: Prospectus

May 30 01:21

8-K: Current report

May 29 19:38

S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

May 18 04:34

8-K: Current report

May 15 20:15

10-Q: Quarterly report

May 14 20:14

8-K: Reviva Reports First Quarter 2024 Financial Results and Recent Business Highlights

May 14 20:14

Reviva Pharmaceuticals | 8-K: Current report

Apr 16 05:05

Reviva Pharmaceuticals | 10-K: Annual report

Apr 15 20:23

Reviva Pharmaceuticals | 8-K: Current report

Apr 15 20:23

Reviva Pharmaceuticals | 8-K: Current report

Apr 15 19:48

Reviva Pharmaceuticals | NT 10-K: Others

Apr 2 20:04

Reviva Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Laxminarayan Bhat(10.2%)

Feb 17 05:37

Reviva Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TANG CAPITAL PARTNERS, LP(9.99%),TANG CAPITAL MANAGEMENT, LLC(9.99%), etc.

Feb 15 05:08

Reviva Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(6.32%),Steven Boyd(6.32%)

Feb 15 04:57

Reviva Pharmaceuticals | EFFECT: Others

Feb 14 19:09

Reviva Pharmaceuticals | 424B4: Prospectus

Feb 14 07:11

Reviva Pharmaceuticals | CORRESP: CORRESP

Feb 10 11:22

Reviva Pharmaceuticals | UPLOAD: Others

Feb 10 11:17

Reviva Pharmaceuticals | S-3: Registration statement for specified transactions by certain issuers

Feb 3 05:43